Discharge Planning
"This presentation will provide an overview of significant changes to Medicare's discharge planning process and highlight opportunities for healthcare providers to play a greater role in ensuring their patient's post-discharge care needs are identified.
At the end of this presentation, the participant will be able to:
Name the 5 key standards in the Discharge Planning Hospital Conditions of Participation.
Describe one or two elements of each standard.
Name the Medicare requirements for reimbursement of commonly ordered respiratory DME.
Describe key roles in improving transitions.
This video is approximately 43 minutes in length."
Speaker Information
Krystal Craddock BS, RRT, RRT-NPS, CCM
Introduction to the AARC Pulmonary Disease Educator Course
"This video introduces the learner to the AARC Pulmonary Disease Educator course.
This video is approximately 3 minutes in length."
Speaker Information
"Disclosures:
There is no conflict of interest for anyone with the ability to control content for this activity except for:
Richard Casaburi MD, MEng, PhD: The presenter discloses relationships with Boehringer Ingelheim, Novartis, GlaxoSmithKline, and Astra Zeneca.
Dabney Eidson BS, RRT, RRT-NPS: The presenter discloses relationships with Chiesi Pharmaceuticals.
Karen Gregory DNP, RRT, AE-C, FAARC: speaking relationships with Novartis, Monaghan Medical, and ALK"
Lung Transplantation
"This presentation will discuss the policies and regulations addressing lung transplantation and when the chronic pulmonary disease patient may qualify for lung transplantation in addition to pre- and post-lung transplantation patient care.
At the end of this presentation, the participant will be able to:
Identify the qualifying measures for listing a patient for lung transplantation
Discuss the self-management behaviors necessary for maintaining status on the transplantation list
Discuss the challenges in adhering to a pre-lung transplantation program
Identify the health behaviors necessary for wellness post-transplantation
Discuss the role of the health care provider in assisting the patient post-transplant
This video is approximately 19 minutes in length."
Speaker Information
David Mason MD
Measurable Outcomes in a Chronic Pulmonary Disease Management Program
"This presentation will discuss the importance of measuring outcomes to the success of the chronic disease management program. In addition, reimbursement and meaningful outcomes measures will be discussed.
At the end of this presentation, the participant will be able to:
Discuss the importance of measuring outcomes to the success of the chronic disease management program
Identify meaningful outcomes measures
Discuss reimbursement
This video is approximately 15 minutes in length."
Speaker Information
Sarah Varekojis PhD, RRT, FAARC
Overview of Disease Management
"This presentation will identify the key components to a comprehensive disease management program and discuss the necessary skills of an effective disease manager.
At the end of this presentation, the participant will be able to:
Identify the key components to a comprehensive disease management program
Describe the importance of and the barriers to patient self-management
Identify the skills necessary to be an effective disease manager
This video is approximately 54 minutes in length."
Speaker Information
Timothy Myers MBA, RRT, RRT-NPS, FAARC
Palliative Care and Chronic Pulmonary Disease
"This presentation will discuss palliative care throughout the spectrum of chronic pulmonary disease, beginning with diagnosis and progressing through end-of-life care.
At the end of this presentation, the participant will be able to:
Differentiate between palliative care and hospice
Identify appropriate timing to initiate hospice
Discuss palliative care in the context of chronic lung disease
This video is approximately 23 minutes in length."
Speaker Information
Shawna Strickland PhD, RRT, RRT-NPS, RRT-ACCS, AE-C, FAARC
Pathophysiology and Assessment
"The first 6 videos in the course focus on COPD, asthma, cystic fibrosis, lung cancer, interstitial lung disease, and pulmonary hypertension.
For each of the disease processes, the participant will be able to:
Explain the pathophysiology of lung cancer
Describe the methods of lung cancer diagnosis
Identify treatment strategies for lung cancer
Describe components of assessment for a patient with lung cancer
The COPD video is approximately 49 minutes in length and is sponsored by the COPD Foundation.
The asthma video is approximately 60 minutes in length and is sponsored by the Allergy & Asthma Network.
The cystic fibrosis video is approximately 54 minutes in length and is sponsored by the Cystic Fibrosis Foundation.
The lung cancer video is approximately 44 minutes in length and is sponsored by the American Lung Association.
The interstitial lung disease video is approximately 27 minutes in length.
The pulmonary hypertension video is approximately 44 minutes in length and is sponsored by the Pulmonary Hypertension Association."
Speaker Information
"COPD: Richard Casaburi MD, MEng, PhD
Asthma: Bradley Chipps MD
Cystic Fibrosis: Dabney Eidson BS, RRT, RRT-NPS
Lung Cancer: Albert Rizzo MD
Interstitial Lung Disease: Shawna Strickland PhD, RRT, RRT-NPS, RRT-ACCS, AE-C, FAARC
Pulmonary Hypertension: Martha Kingman DNP, FNP-C"
Patient Education
"This presentation will discuss the essential components of effective communication and patient education, including basic adult learning theory, barriers to learning, and transitional care.
At the end of this presentation, the participant will be able to:
Identify essential components of effective communication and patient education
Describe basic adult learning theory
Identify barriers to learning
Discuss issues with transitional care
This video is approximately 43 minutes in length.
This presentation is sponsored by Allergy & Asthma Network."
Speaker Information
Tonya Winders, MBA
Pharmacologic Interventions
"This presentation will discuss currently available pulmonary medications and their indications, delivery methods, and medication interaction.
At the end of this presentation, the participant will be able to:
List currently available pulmonary medications
Describe indications for various pulmonary medications based on scientific evidence and use in specific disease processes
Determine appropriate delivery method for inhaled medications based on patient cognition, physical ability, and preference
This video is approximately 1 hour and 23 minutes in length."
Speaker Information
Timothy Myers MBA, RRT, RRT-NPS, FAARC
Pulmonary Disease and Nutrition: Basic Concepts
"This presentation will discuss malnutrition in the context of pulmonary disease and developing nutrition strategies for patients with pulmonary disease.
At the end of this presentation, the participant will be able to:
Describe the measurement of malnutrition
Describe the effects of malnutrition on patients with pulmonary disease
Develop a nutrition strategy for patients with pulmonary disease
This video is approximately 24 minutes in length."
Speaker Information
Karen Gregory DNP, RRT, AE-C, FAARC
Pulmonary Function Testing
"This presentation will assist the participant in differentiating the various types of pulmonary function tests and their use among the disease processes discussed in the course as well as identifying disease severity based on pulmonary function test results.
At the end of this presentation, the participant will be able to:
Define three types of pulmonary function tests
Review reference equations/predicted values/lower limits of normal
Describe quality testing criteria
Describe and review lung volumes and capacities
Identify specific pulmonary abnormalities with pulmonary function tests
Identify disease severity with pulmonary function tests
This video is approximately 47 minutes in length."
Speaker Information
Curt Merriman BA, RRT, CPFT
Pulmonary Rehabilitation
"This presentation will define pulmonary rehabilitation and describe the essential components of a comprehensive pulmonary rehabilitation program.
At the end of this presentation, the participant will be able to:
Define pulmonary rehabilitation
Describe the essential components of a comprehensive pulmonary rehabilitation program
Explain the benefits of pulmonary rehabilitation
This video is approximately 1 hour and 13 minutes in length.
This presentation is sponsored by the American Association of Cardiovascular and Pulmonary Rehabilitation."
Speaker Information
Trina Limberg BS, RRT, FAARC, MAACVPRT
Respiratory Exacerbation Management
"This presentation will assist the learner in identifying respiratory changes that indicate the presence of pulmonary disease exacerbation and determining appropriate interventions for various severity levels of exacerbations.
At the end of this presentation, the participant will be able to:
Identify respiratory changes that indicate the presence of a pulmonary disease exacerbation
Recognize the severity level of an exacerbation
Determine appropriate interventions for various severity levels of exacerbations
This video is approximately 27 minutes in length."
Speaker Information
Karen Gregory DNP, RRT, AE-C, FAARC
Supplemental Oxygen Administration
"This presentation will describe the physiologic benefit of supplemental oxygen while also assisting the health care professional in differentiating between home systems and determining the appropriate delivery system to meet patient need.
At the end of this presentation, the participant will be able to:
Describe the physiological benefit of supplemental oxygen
Differentiate between various home oxygen delivery systems
Determine appropriate delivery system to meet patient need
This video is approximately 37 minutes in length."
Speaker Information
Curt Merriman BA, RRT, CPFT
Tobacco Cessation
"This presentation will explain the scientific factors supporting tobacco cessation, general approaches to smoking cessation, and pharmacologic agents in tobacco cessation programs.
At the end of this presentation, the participant will be able to:
Explain the scientific factors supporting tobacco cessation
Identify general approaches to smoking cessation
Explain the pharmacologic agents employed in a tobacco cessation program.
Identify the barriers to tobacco cessation
Describe motivational interviewing
Demonstrate effective motivational interviewing skills.
The video for part 1 is approximately 23 minutes in length and part 2 is approximately 22 minutes in length."
Speaker Information
Sarah Varekojis PhD, RRT, FAARC